컨텐츠 영역
Risk assessment for the use of healthcare-related living modified organisms
- Entities who wish to import, produce, or utilize LMOs for health and medical purposes must undergo a risk assessment by the Korea Disease Control Agency in accordance with Article 7-2 (1) of the Act on Transboundary Movements, etc. of Living Modified Organisms.
- The risk assessment of living modified organisms is evaluated through a comparative analysis with existing species (non-living modified host organisms).
This image provides an overview of the risk assessment process for genetically modified organisms (LMOs). It distinguishes between risks to human health and risks to the environment by comparatively analyzing LMOs and conventional comparator organisms.
- Human Health Risks:
- Direct toxicity
- Indirect characteristics
- Infectivity and transmissibility
- Allergenicity
- Effects on metabolic pathways
- Human health risks of by-products
- Generation of unintended products, etc.
- Environmental Risks:
- Effects of LMOs on environmental factors and the characteristics of surrounding organisms
- Risks to human health posed by altered environments
- Risks to human health posed by altered surrounding organisms
Meaning: The risk assessment of genetically modified organisms is a procedure that comprehensively evaluates toxicity, potential infectivity, and ecological impacts from both human health and environmental perspectives.
Risk assessment procedure for living modified organisms for healthcare use
This image is a flowchart illustrating the risk review procedure for healthcare-related genetically modified organisms (LMOs).
- Application Stage: The applicant submits an application for risk assessment to the Korea Disease Control and Prevention Agency (KDCA, Division of Biosafety Assessment).
- Data Submission: Submission of new data or supplementary data.
- Internal Review: Following an internal review of the submitted materials, an official request for review is issued.
- Review: The Risk Assessment Subcommittee conducts the review. The result is determined as either compliant or non-compliant.
- Result Processing:
- If compliant → Approval is granted and follow-up actions may proceed.
- If non-compliant → The review result is notified and the application is rejected.
- Follow-up Actions: Based on the review results, subsequent procedures such as applications for approval to import, produce, or use the LMO are carried out.
Meaning: Healthcare-related LMOs undergo thorough data submission, review, and committee evaluation to determine compliance, and the final outcome—approval or rejection—is decided based on the review results.
[보건의료용 LMO 위해성심사 절차]
Documents to be submitted for risk assessment of living modified organisms for healthcare use
-
- Application form for risk assessment of living modified organisms
- Submission table for risk assessment data
- Risk assessment data for living modified organisms
- Korean summary of the risk assessment report
- Supporting documents for submitted materials (references, standards, etc.)
- Government import approval - Issuance for administrative fees (4 million KRW)
- Safety management guide for living modified organisms
The risk assessment data submitted when applying for risk assessment of LMOs for healthcare use must meet the requirements specified in Article 5-2 of the “Consolidated Notice on the Transboundary Movements, etc. of Living Modified Organisms.
- Data published in professional journals
- Data tested according to Good Laboratory Practice (GLP) standards
- Data tested at domestic and international specialized institutions such as universities or research organizations, issued by the head of the institution, and reviewed to be deemed valid, which must include an overview of the research facility, major equipment, composition of research personnel, and the research experience of the testers
- Data submitted during the risk assessment of living modified organisms in foreign countries; documents must confirm that the foreign government has approved the use of living modified organisms
Application procedure for risk assessment of LMOs for healthcare use
- Application documents: Submit the application documents along with the application for risk assessment of living modified organisms.
- How to submit: Submit one printed copy and 12 electronic copies of the documents either by electronic mail or by post. If submitting by email, the original must be sent by mail.
- Where to submit: Biological Safety Assessment Division, Centers for Disease Control and Prevention
- Processing period (If there is a document supplementation period, the supplementation period is not included in the processing deadline.)
- Notification of results: Within 270 days